Literature DB >> 15351779

New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.

Lucie Rivail1, Mireille Giner, Monique Gastineau, Magali Berthouze, Jean-Louis Soulier, Rodolphe Fischmeister, Frank Lezoualc'h, Bernard Maigret, Sames Sicsic, Isabelle Berque-Bestel.   

Abstract

A body of evidences suggests that a hydrophobic pocket of the human 5-HT(4) receptor contributes to the high affinity of some bulky 5-HT(4) ligands. A thorough study of this pocket was performed using mutagenesis and molecular modeling. Ligand binding or competition studies with selected bulky ligands (RS39604, RS100235, [(3)H]GR113808 and ML11411) and small ligands (5-HT and ML10375) were carried out on wild-type and mutant receptors (W7.40A/F, Y7.43F, R3.28L) transiently transfected in COS-7 cells. The functional activity of the mutated receptors was evaluated by measuring the ability of 5-HT to stimulate adenylyl cyclase. For W7.40F mutation, no changes in the affinity of studied ligands and in the functional activity of the mutant receptor were observed, in contrary to W7.40A mutation, which abolished both binding of ligands and 5-HT-induced cAMP production. Mutation R3.28L revealed a totally silent receptor with a basal level of cAMP production similar to the mock control despite its ability to product cAMP in the presence of 5-HT. Moreover, a one order loss of affinity of RS39604 and a 45-fold increase of ML11411 affinity were observed. Mutation Y7.43F modified the affinity of GR113808, which displays a 13-fold lower affinity for the mutant than for the wild-type receptor. In conclusion, in the hydrophobic pocket, two polar amino acids are able to interact through hydrogen bonds with bulky ligands depending on their chemical properties. Moreover, these experimental data may validate the proposed new three-dimensional model of the human 5-HT(4) receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351779      PMCID: PMC1575351          DOI: 10.1038/sj.bjp.0705950

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines.

Authors:  J Mialet; I Berque-Bestel; P Eftekhari; M Gastineau; M Giner; Y Dahmoune; P Donzeau-Gouge; J Hoebeke; M Langlois; S Sicsic; R Fischmeister; F Lezoualc'h
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

Review 3.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

Authors:  J A Ballesteros; L Shi; J A Javitch
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 4.  5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.

Authors:  M L López-Rodriguez; B Benhamú; M J Morcillo; M Murcia; A Viso; M Campillo; L Pardob
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

5.  Molecular design based on 3D-pharmacophore. Application to 5-HT4 receptor.

Authors:  Ronan Bureau; Cyril Daveu; Stéphane Lemaître; François Dauphin; Henriette Landelle; Jean-Charles Lancelot; Sylvain Rault
Journal:  J Chem Inf Comput Sci       Date:  2002 Jul-Aug

6.  Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6.

Authors:  David A Shapiro; Kurt Kristiansen; David M Weiner; Wesley K Kroeze; Bryan L Roth
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

7.  Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin.

Authors:  M L López-Rodríguez; M Murcia; B Benhamú; M Olivella; M Campillo; L Pardo
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

Review 8.  Rhodopsin: insights from recent structural studies.

Authors:  Thomas P Sakmar; Santosh T Menon; Ethan P Marin; Elias S Awad
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001-10-25

Review 9.  New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease?

Authors:  Marjorie Maillet; Sylvain J Robert; Frank Lezoualc'h
Journal:  Curr Alzheimer Res       Date:  2004-05       Impact factor: 3.498

10.  The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein.

Authors:  S J Robert; J L Zugaza; R Fischmeister; A M Gardier; F Lezoualc'h
Journal:  J Biol Chem       Date:  2001-10-02       Impact factor: 5.157

View more
  9 in total

1.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Serotonin G Protein-Coupled Receptor-Based Biosensing Modalities in Yeast.

Authors:  Bettina Lengger; Emma E Hoch-Schneider; Christina N Jensen; Tadas Jakočiu Nas; Anja A Petersen; Thomas M Frimurer; Emil D Jensen; Michael K Jensen
Journal:  ACS Sens       Date:  2022-04-22       Impact factor: 9.618

4.  A hybrid structural approach to analyze ligand binding by the serotonin type 4 receptor (5-HT4).

Authors:  Pius S Padayatti; Liwen Wang; Sayan Gupta; Tivadar Orban; Wenyu Sun; David Salom; Steven R Jordan; Krzysztof Palczewski; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2013-02-01       Impact factor: 5.911

5.  Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.

Authors:  Emmanuelle Dubost; Noé Dumas; Christine Fossey; Rosa Magnelli; Sabrina Butt-Gueulle; Céline Ballandonne; Daniel H Caignard; Fabienne Dulin; Jana Sopkova de-Oliveira Santos; Philippe Millet; Yves Charnay; Sylvain Rault; Thomas Cailly; Frederic Fabis
Journal:  J Med Chem       Date:  2012-11-09       Impact factor: 7.446

6.  Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer's Disease Treatment through Rigidification Strategy.

Authors:  Cédric Lecoutey; Rémi Legay; Audrey Davis; Jana Sopková-de Oliveira Santos; Patrick Dallemagne; Christophe Rochais
Journal:  Molecules       Date:  2021-04-26       Impact factor: 4.411

7.  Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor.

Authors:  Wei Chun Chang; Jennifer K Ng; Trieu Nguyen; Lucie Pellissier; Sylvie Claeysen; Edward C Hsiao; Bruce R Conklin
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

8.  Structural basis for recognition of antihistamine drug by human histamine receptor.

Authors:  Xueqian Peng; Linlin Yang; Zixuan Liu; Siyi Lou; Shiliu Mei; Meiling Li; Zhong Chen; Haitao Zhang
Journal:  Nat Commun       Date:  2022-10-15       Impact factor: 17.694

9.  Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer's disease.

Authors:  Julien Lalut; Hugo Payan; Audrey Davis; Cédric Lecoutey; Rémi Legay; Jana Sopkova-de Oliveira Santos; Sylvie Claeysen; Patrick Dallemagne; Christophe Rochais
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.